Pacific Biosciences of California, Inc.
PACB
$1.13
$0.043.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.02% | -27.54% | -25.43% | 7.44% | 2.39% |
| Total Depreciation and Amortization | 101.07% | 179.17% | 138.26% | 92.90% | 53.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.80% | 94.05% | 56.07% | -33.97% | -8.79% |
| Change in Net Operating Assets | 31.17% | 0.38% | 11.67% | 43.08% | -9.24% |
| Cash from Operations | 20.49% | 11.14% | 2.83% | 13.88% | 1.53% |
| Capital Expenditure | 30.02% | 43.74% | 45.55% | 46.53% | 47.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 860.90% | -96.46% | 1,142.54% | 184.68% | -89.80% |
| Cash from Investing | 2,593.40% | -100.53% | 693.08% | 2,812.73% | -96.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2,651.90% | 48.77% | 18.75% | -3.40% | -14.55% |
| Issuance of Common Stock | -96.23% | -95.78% | -93.92% | -92.59% | 1,721.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.47% | -602.07% | -1,171.94% | -- | -- |
| Cash from Financing | -139.48% | -138.88% | -138.92% | -140.19% | 1,031.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.17% | -481.80% | -8.42% | -260.63% | -5.94% |